UNITEDHEALTH GROUP INC
UNHAPI behind this page
UNH Q2 2025 request
Playground key active
/api/financials?ticker=UNH&year=2025&quarter=2
Pick an endpoint and run the request.Income Statement
| Metric | Q2 2025 | Q2 2024 | YoY |
|---|---|---|---|
| Premiums Earned Net | 87,905 | 76,897 | +14.3% |
Show Business Segments breakouts |
|||
| Optum Health · Operating Segments | 4,886 | 5,947 | -17.8% |
| Optum · Unaffiliated Customers | 4,886 | 5,947 | -17.8% |
| UnitedHealthcare · Operating Segments | 83,019 | 70,950 | +17.0% |
Show Major Customers breakouts |
|||
| Unaffiliated Customers | 87,905 | 76,897 | +14.3% |
| Investment Income Interest And Dividend | 1,108 | 997 | +11.1% |
Show Business Segments breakouts |
|||
| Optum | 535 | 469 | +14.1% |
| Optum Health · Operating Segments | 455 | 382 | +19.1% |
| Optum Insight · Operating Segments | 32 | 27 | +18.5% |
| Optum Rx · Operating Segments | 48 | 60 | -20.0% |
| UnitedHealthcare · Operating Segments | 573 | 528 | +8.5% |
| Revenue | 111,616 | 98,855 | +12.9% |
Show Business Segments breakouts |
|||
| Optum | 67,225 | 62,879 | +6.9% |
| Optum Health · Operating Segments | 8,797 | 10,092 | -12.8% |
| Optum Health · Operating Segments | 15,953 | 16,576 | -3.8% |
| Optum Health · Operating Segments | 25,205 | 27,050 | -6.8% |
| Optum Insight · Operating Segments | 1,560 | 1,446 | +7.9% |
| Optum Insight · Operating Segments | 3,236 | 3,070 | +5.4% |
| Optum Insight · Operating Segments | 4,828 | 4,543 | +6.3% |
| Optum Rx · Operating Segments | 14,621 | 12,982 | +12.6% |
| Optum Rx · Operating Segments | 23,790 | 19,373 | +22.8% |
| Optum Rx · Operating Segments | 38,459 | 32,415 | +18.6% |
| Optum · Affiliated Customers | 41,712 | 37,890 | +10.1% |
| Optum · Unaffiliated Customers | 24,978 | 24,520 | +1.9% |
| UnitedHealthcare · Operating Segments | 85,530 | 73,338 | +16.6% |
| UnitedHealthcare · Operating Segments | 86,103 | 73,866 | +16.6% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -41,712 | -37,890 | -10.1% |
| Corporate Non Segment · Affiliated Customers | -41,712 | -37,890 | -10.1% |
| Intersegment Elimination | -1,267 | -1,129 | -12.2% |
| Intersegment Elimination · Affiliated Customers | -1,267 | -1,129 | -12.2% |
Show Major Customers breakouts |
|||
| Unaffiliated Customers | 110,508 | 97,858 | +12.9% |
| Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Product | 13,564 | 12,211 | +11.1% |
| Product · Optum | 13,564 | 12,211 | +11.1% |
| Product · Optum Health | 65 | 62 | +4.8% |
| Product · Optum Insight | 44 | 41 | +7.3% |
| Product · Optum Rx | 13,455 | 12,108 | +11.1% |
| Product · Unaffiliated Customers | 13,564 | 12,211 | +11.1% |
| Service | 9,039 | 8,750 | +3.3% |
| Service · Optum | 6,528 | 6,362 | +2.6% |
| Service · Optum Health | 3,846 | 4,083 | -5.8% |
| Service · Optum Insight | 1,516 | 1,405 | +7.9% |
| Service · Optum Rx | 1,166 | 874 | +33.4% |
| Service · Unaffiliated Customers | 9,039 | 8,750 | +3.3% |
| Service · UnitedHealthcare | 2,511 | 2,388 | +5.2% |
| Policyholder Benefits And Claims Incurred Net | 78,585 | 65,458 | +20.1% |
| Selling, General & Administrative | 13,778 | 13,162 | +4.7% |
| Cost of Revenue | 13,019 | 11,340 | +14.8% |
| Depreciation And Amortization | 1,084 | 1,020 | +6.3% |
Show Business Segments breakouts |
|||
| Optum | 863 | 799 | +8.0% |
| Optum Health · Operating Segments | 296 | 277 | +6.9% |
| Optum Insight · Operating Segments | 351 | 316 | +11.1% |
| Optum Rx · Operating Segments | 216 | 206 | +4.9% |
| UnitedHealthcare · Operating Segments | 221 | 221 | 0.0% |
| Total Costs & Expenses | 106,466 | 90,980 | +17.0% |
Show Business Segments breakouts |
|||
| Optum | 64,150 | 59,008 | +8.7% |
| Optum Health · Operating Segments | 24,569 | 25,131 | -2.2% |
| Optum Insight · Operating Segments | 3,830 | 3,997 | -4.2% |
| Optum Rx · Operating Segments | 37,018 | 31,009 | +19.4% |
| UnitedHealthcare · Operating Segments | 84,028 | 69,862 | +20.3% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -41,712 | -37,890 | -10.1% |
| Intersegment Elimination | -1,267 | -1,129 | -12.2% |
| Operating Income | 5,150 | 7,875 | -34.6% |
Show Business Segments breakouts |
|||
| Optum | 3,075 | 3,871 | -20.6% |
| Optum Health · Operating Segments | 636 | 1,919 | -66.9% |
| Optum Insight · Operating Segments | 998 | 546 | +82.8% |
| Optum Rx · Operating Segments | 1,441 | 1,406 | +2.5% |
| UnitedHealthcare · Operating Segments | 2,075 | 4,004 | -48.2% |
| Interest Expense | -1,027 | -985 | -4.3% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -1,027 | -985 | -4.3% |
| Loss On Sale Of Subsidiary And Subsidiaries Held For Sale | -41 | -1,225 | +96.7% |
Show Business Segments breakouts |
|||
| UnitedHealthcare · Operating Segments | -41 | -1,225 | +96.7% |
| Income Before Taxes | 4,082 | 5,665 | -27.9% |
Show Business Segments breakouts |
|||
| Optum | 3,075 | 3,871 | -20.6% |
| Optum Health · Operating Segments | 636 | 1,919 | -66.9% |
| Optum Insight · Operating Segments | 998 | 546 | +82.8% |
| Optum Rx · Operating Segments | 1,441 | 1,406 | +2.5% |
| UnitedHealthcare · Operating Segments | 2,034 | 2,779 | -26.8% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -1,027 | -985 | -4.3% |
| Income Tax Expense (Benefit) | -510 | -1,244 | +59.0% |
| Net Income | 3,572 | 4,421 | -19.2% |
| Net Income Loss Attributable To Noncontrolling Interest | -166 | -205 | +19.0% |
| Net Income | 3,406 | 4,216 | -19.2% |
Show Equity Components breakouts |
|||
| Retained Earnings | 3,406 | 4,216 | -19.2% |
| EPS (Basic) | 3.76 | 4.58 | -17.9% |
| EPS (Diluted) | 3.74 | 4.54 | -17.6% |
| Wtd Avg Shares (Basic) | 907 | 921 | -1.5% |
| Weighted Average Number Diluted Shares Outstanding Adjustment | 3 | 7 | -57.1% |
| Wtd Avg Shares (Diluted) | 910 | 928 | -1.9% |
| Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount | 13 | 8 | +62.5% |
| Comprehensive Income | 3,776 | 4,232 | -10.8% |
Balance Sheet
| Metric | Q2 2025 | Q2 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 28,596 | 26,286 | +8.8% |
| Short-Term Investments | 3,424 | 5,037 | -32.0% |
| Accounts Receivable | 24,142 | 23,115 | +4.4% |
Show Product Lines breakouts |
|||
| unh:ProductsandservicesMember | 9.8 | 9 | +8.9% |
| Other Receivables Net Current | 28,582 | 26,762 | +6.8% |
| Prepaid Expenses & Other Current Assets | 8,955 | 7,424 | +20.6% |
| Total Current Assets | 93,699 | 92,038 | +1.8% |
| Non-Current Assets | |||
| Long Term Investments | 52,466 | 46,113 | +13.8% |
| Property, Plant & Equipment | 10,923 | 9,801 | +11.4% |
| Goodwill | 107,677 | 105,436 | +2.1% |
| Other Non-Current Assets | 21,298 | 17,939 | +18.7% |
| Total Assets | 308,573 | 286,056 | +7.9% |
Show Business Segments breakouts |
|||
| Optum | 191,842 | 184,160 | +4.2% |
| Optum Health · Operating Segments | 96,452 | 93,858 | +2.8% |
| Optum Insight · Operating Segments | 33,716 | 34,244 | -1.5% |
| Optum Rx · Operating Segments | 61,674 | 56,058 | +10.0% |
| UnitedHealthcare · Operating Segments | 129,587 | 109,441 | +18.4% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -12,856 | -7,545 | -70.4% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 22,510 | 14,729 | +52.8% |
| Current Liabilities | |||
| Liability For Claims And Claims Adjustment Expense | 38,427 | 32,547 | +18.1% |
| Accounts Payable And Accrued Liabilities Current | 34,330 | 30,886 | +11.2% |
| Debt Current | 5,698 | 11,371 | -49.9% |
| Deferred Revenue | 3,032 | 2,572 | +17.9% |
| Other Liabilities Current | 29,294 | 27,294 | +7.3% |
| Total Current Liabilities | 110,781 | 104,670 | +5.8% |
| Non-Current Liabilities | |||
| Long-Term Debt | 73,495 | 63,727 | +15.3% |
| Deferred Tax Liabilities | 3,804 | 3,631 | +4.8% |
| Other Non-Current Liabilities | 15,709 | 14,794 | +6.2% |
| Total Liabilities | 203,789 | 186,822 | +9.1% |
| Other Liabilities | |||
| Redeemable Noncontrolling Interest Equity Carrying Amount | 4,315 | 4,558 | -5.3% |
| Stockholders' Equity | |||
| Common Stock | 9 | 9 | 0.0% |
| Retained Earnings | 97,250 | 92,400 | +5.2% |
| Accumulated Other Comprehensive Income | -2,535 | -3,423 | +25.9% |
| Minority Interest | 5,745 | 5,317 | +8.0% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 100,469 | 94,676 | +6.1% |
Show Equity Components breakouts |
|||
| Accumulated Net Unrealized Investment Gain Loss | -1,593 | -2,296 | +30.6% |
| Accumulated Translation Adjustment | -942 | -1,127 | +16.4% |
| Common Stock | 9 | 9 | 0.0% |
| Noncontrolling Interest | 5,745 | 5,317 | +8.0% |
| Retained Earnings | 97,250 | 92,400 | +5.2% |
| Total Liabilities & Equity | 308,573 | 286,056 | +7.9% |
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.0% |
| Common Stock Shares Authorized | 3,000 | 3,000 | 0.0% |
| Common Stock Shares Issued | 905 | 921 | -1.7% |
| Common Stock Shares Outstanding | 905 | 921 | -1.7% |
Show Equity Components breakouts |
|||
| Common Stock | 905 | 921 | -1.7% |
| Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0.0% |
| Preferred Stock Shares Authorized | 10 | 10 | 0.0% |
Cash Flow Statement
| Metric | YTD Q2 2025 | YTD Q2 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Deferred Income Taxes | -87 | -358 | +75.7% |
| Stock-Based Compensation | 572 | 594 | -3.7% |
| Other Non-Cash Items | 127 | 459 | -72.3% |
| Change in Accounts Receivable | -1,681 | -2,471 | +32.0% |
| Increase Decrease In Other Operating Assets | -2,143 | -4,121 | +48.0% |
| Increase Decrease In Health Care Insurance Liabilities | 4,371 | 777 | +462.5% |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -480 | 36 | -1433.3% |
| Increase Decrease In Deferred Revenue | -282 | -554 | +49.1% |
| Net Cash from Operations | 12,644 | 7,890 | +60.3% |
| Investing Activities | |||
| Payments To Acquire Investments | -8,180 | -10,130 | +19.2% |
| Proceeds From Sale Of Available For Sale Securities Debt | 5,181 | 5,288 | -2.0% |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | 4,326 | 4,621 | -6.4% |
| Payments To Acquire Businesses Net Of Cash Acquired | -734 | -3,031 | +75.8% |
| Capital Expenditures | -1,784 | -1,596 | -11.8% |
| Repayments Of Care Provider Loans Cyberattack | 1,293 | 604 | +114.1% |
| Other Investing Activities | -1,618 | -1,413 | -14.5% |
| Net Cash from Investing | -1,516 | -13,757 | +89.0% |
| Financing Activities | |||
| Share Repurchases | -5,545 | -3,072 | -80.5% |
| Payments Of Dividends Common Stock | -3,912 | -3,664 | -6.8% |
| Proceeds From Issuance Of Common Stock | 581 | 744 | -21.9% |
| Proceeds From Repayments Of Commercial Paper | -1,403 | 8,615 | -116.3% |
| Proceeds From Issuance Of Long Term Debt | 2,969 | 5,925 | -49.9% |
| Increase Decrease In Deposits | -25 | 990 | -102.5% |
| Proceeds From Payments For Other Financing Activities | -513 | -753 | +31.9% |
| Net Cash from Financing | -7,848 | 7,035 | -211.6% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 29 | -44 | +165.9% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations | 3,309 | 1,124 | +194.4% |
| Increase In Cash Within Businesses Held For Sale | -25 | -265 | +90.6% |
| Net Change in Cash | 3,284 | 859 | +282.3% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 28,596 | 26,286 | +8.8% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.